Literature DB >> 15972544

Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli.

Ursula M Talbot1, James C Paton, Adrienne W Paton.   

Abstract

We have recently described a novel AB(5) cytotoxin produced by certain Shiga toxin-producing Escherichia coli strains. The A subunit of this toxin is a subtilase-like serine protease, while the B pentamer mediates binding to host cell glycolipid receptors. The subtilase cytotoxin is lethal for mice, causing extensive microvascular thrombosis as well as necrosis in the brain, kidneys, and liver. In the present study, we have immunized mice with a purified derivative of the toxin with a Ser272 --> Ala mutation in the A subunit which abolishes cytotoxicity. This elicited strong antibody responses, as judged by enzyme-linked immunosorbent assay, which conferred protection against intraperitoneal challenge with purified toxin. Immunized mice were also protected from weight loss resulting from oral challenge with an E. coli K-12 clone expressing the active toxin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972544      PMCID: PMC1168599          DOI: 10.1128/IAI.73.7.4432-4436.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.

Authors:  Satoshi Ishikawa; Kazuyoshi Kawahara; Yutaka Kagami; Yasunori Isshiki; Aki Kaneko; Hidenori Matsui; Nobuhiko Okada; Hirofumi Danbara
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 2.  Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases.

Authors:  R J Siezen; W M de Vos; J A Leunissen; B W Dijkstra
Journal:  Protein Eng       Date:  1991-10

3.  Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZ alpha and pUC18 or pUC19 multiple cloning sites.

Authors:  M G Jobling; R K Holmes
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

4.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.

Authors:  A W Paton; M C Woodrow; R M Doyle; J A Lanser; J C Paton
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine.

Authors:  V M Gordon; S C Whipp; H W Moon; A D O'Brien; J E Samuel
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

Review 7.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

8.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.

Authors:  S M Ostroff; P I Tarr; M A Neill; J H Lewis; N Hargrett-Bean; J M Kobayashi
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

9.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933.

Authors:  H Schmidt; L Beutin; H Karch
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.

Authors:  Adrienne W Paton; Potjanee Srimanote; Ursula M Talbot; Hui Wang; James C Paton
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  19 in total

1.  Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.

Authors:  Hui Wang; James C Paton; Cheleste M Thorpe; Claudine S Bonder; Wai Yan Sun; Adrienne W Paton
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways.

Authors:  Jennifer J Wolfson; Kerrie L May; Cheleste M Thorpe; Dakshina M Jandhyala; James C Paton; Adrienne W Paton
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

3.  In Vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin.

Authors:  Hui Wang; Adrienne W Paton; Shaun R McColl; James C Paton
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

4.  The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones.

Authors:  Carrie R Sowers; Rong Wang; Rebecca A Bourne; Barbara C McGrath; Jingjie Hu; Sarah C Bevilacqua; James C Paton; Adrienne W Paton; Sophie Collardeau-Frachon; Marc Nicolino; Douglas R Cavener
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

5.  Escherichia coli Subtilase Cytotoxin.

Authors:  Adrienne W Paton; James C Paton
Journal:  Toxins (Basel)       Date:  2010-02-01       Impact factor: 4.546

6.  Decreased ER-associated degradation of alpha-TCR induced by Grp78 depletion with the SubAB cytotoxin.

Authors:  Agnieszka Lass; Marek Kujawa; Elizabeth McConnell; Adrienne W Paton; James C Paton; Cezary Wójcik
Journal:  Int J Biochem Cell Biol       Date:  2008-06-20       Impact factor: 5.085

7.  Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.

Authors:  Max Brown; Samantha Dainty; Natalie Strudwick; Adina D Mihai; Jamie N Watson; Robina Dendooven; Adrienne W Paton; James C Paton; Martin Schröder
Journal:  Mol Biol Cell       Date:  2020-09-02       Impact factor: 4.138

8.  Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly.

Authors:  Nicholas J Buchkovich; Tobi G Maguire; Yongjun Yu; Adrienne W Paton; James C Paton; James C Alwine
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin.

Authors:  Emma Byres; Adrienne W Paton; James C Paton; Jonas C Löfling; David F Smith; Matthew C J Wilce; Ursula M Talbot; Damien C Chong; Hai Yu; Shengshu Huang; Xi Chen; Nissi M Varki; Ajit Varki; Jamie Rossjohn; Travis Beddoe
Journal:  Nature       Date:  2008-10-29       Impact factor: 49.962

10.  Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes.

Authors:  Chih-Chi Andrew Hu; Stephanie K Dougan; Sebastian Virreira Winter; Adrienne W Paton; James C Paton; Hidde L Ploegh
Journal:  J Exp Med       Date:  2009-10-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.